MenaQ7® is the natural, clinically proven Vitamin K2 as MK-7, backed by nearly two decades of clinical evidence, all gathered in a single comprehensive scientific white paper.
A comprehensive scientific white paper revealing insights from close to two decades of proprietary and published clinical research on MenaQ7® Vitamin K2 as MK-7 is now accessible. This document examines the proven benefits in bone and cardiovascular health, the impact of vitamin K2 status throughout various life stages, and emerging research exploring its role in brain function and metabolic health. Designed as a structured, evidence-based resource, the white paper supports R&D professionals, regulatory personnel, scientific teams, and product developers in the dietary supplement and functional food sectors.
A Singular Ingredient Supported by Exceptional Science
Not all Vitamin K2 ingredients are scientifically equivalent. The bioform, manufacturing process, and clinical validation program behind an ingredient determine its credibility — and, ultimately, your product’s ability to substantiate health claims.
MenaQ7® is the first and most clinically proven natural Vitamin K2 as MK-7, supported by numerous proprietary clinical studies covering all life stages. Produced through a controlled natural fermentation process using non-GMO Bacillus strains on an allergen-free substrate, MenaQ7® is a highly pure ingredient — with a general purity exceeding 97% and an isomeric purity of 99.8% in the bioactive all-trans MK-7 form.
This groundbreaking white paper consolidates nearly 20 years of studies, offering R&D teams, regulatory specialists, scientists, and brand owners a well-structured reference document with evidence-graded data to support key product formulation decisions.
Built to Serve Multidisciplinary Teams
Structured to fulfill the needs of diverse professionals, the white paper provides tailored data to assist cross-functional teams. Whether evaluating clinical evidence, strategizing health claims, or assessing ingredient quality benchmarks, this comprehensive document equips teams with the insights necessary to make informed decisions.
Inside the MenaQ7® Clinical White Paper
From the dual mechanism of action that directs calcium toward bone and away from arteries to randomized controlled trial data on bone strength, arterial elasticity, and coronary calcification — supported by a clinically documented safety profile — this white paper covers the full scientific rationale for formulating with MenaQ7®:
Executive Summary
– The Vitamin K Family — chemistry, sources, and regional intake recommendations
– MenaQ7® — manufacturing process and quality specifications
– Pharmacokinetics and Mechanism of Action
– The Calcium Paradox — Vitamin K2, Vitamin D, and Magnesium
– Clinical Evidence — bone health in adults and children, cardiovascular health, vitamin K status, emerging research
– Safety Profile
Access the comprehensive scientific dossier on MenaQ7®, the most thoroughly researched Vitamin K2 ingredient worldwide. Whether focusing on its established benefits in bone and heart health or exploring emerging applications, the evidence-packed white paper provides everything necessary to guide your formulation team.